查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514028

生物成像成像技术的全球市场

BioImaging Technologies
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 174 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球生物成像成像技术市场预计将达到 316 亿美元

2023年全球生物成像成像技术市场估计为119亿美元，预计到2030年将达到316亿美元，2023年至2030年复合年增长率为15.0%。医疗技术是本报告分析的细分市场之一，预计复合年增长率为 14.7%，到分析期结束时将达到 195 亿美元。分析期间分子技术产业的复合年增长率预计为 15.5%。

美国市场预计33亿美元，中国预计复合年增长率14.2%

预计 2023 年美国生物成像成像技术市场规模将达 33 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达48亿美元，2023-2030年分析期间复合年增长率为14.2%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间复合年增长率分别为 13.0% 和 12.6%。在欧洲，德国预计复合年增长率为 10.7%。

全球成像技术市场—主要趋势与驱动因素总结

成像技术透过即时可视化生物过程，彻底改变了医学。透过将解剖结构资讯与电场和磁场、机械运动和代谢过程等功能资料相结合，生物成像提供了人体内部运作的全面视图。 X 光、超音波、MRI 和先进电脑断层扫描等技术可显示解剖和细胞结构的详细影像，对于疾病诊断和管理至关重要。这些非侵入性方法可以在没有物理侵入的情况下进行详细检查，使其在临床实践中具有无价的价值。生物影像是一个跨学科领域，它整合了电气、机械和生物医学工程来解决复杂的生物学问题，从而在癌症等疾病的理解和治疗方面取得了重大进展。

生物成像的进步深深植根于计算生物学和生物资讯学，并专注于细胞和分子影像的高通量分析。现代自动显微镜和先进的计算技术提高了资料分析的准确性和效率，同时最大限度地减少了人为干预。多光子成像、影像引导干预和各种显微镜技术等创新扩大了医疗诊断和治疗计划的能力。生物成像的关键挑战之一以及影像处理技术的计算复杂性是与影像重建相关的数值不稳定性。最近的趋势包括整合人工智慧 (AI) 和机器学习，以增强影像分析并将原始资料转化为可行的医学见解。

有几个重要因素促进了成像技术的发展。人工智慧和机器学习的进步可以实现更复杂的分析，提高诊断准确性和效率。增强的运算能力和卓越的演算法可实现更快、更可靠的影像处理。对个人化医疗的需求不断增长，需要先进的影像技术来根据个人的生理和分子特征量身定制治疗方法。扩大生物医学研究需要在细胞和分子层面上观察和分析生物过程，从而推动了对先进成像工具的需求。不断增长的医疗保健支出，尤其是在新兴国家，正在推动生物成像的采用。患者意识的提高和对早期准确诊断的期望，以及支持性监管政策和成像技术成本的降低，正在进一步推动生物成像系统在医疗保健领域的采用。这些因素共同支持了生物成像在现代医学和科学领域的重要角色。

受访企业范例（14家知名企业）

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 世界其他地区

第四章 比赛

简介目录
Product Code: MCP-7637

Global BioImaging Technologies Market to Reach US$31.6 Billion by 2030

The global market for BioImaging Technologies estimated at US$11.9 Billion in the year 2023, is expected to reach US$31.6 Billion by 2030, growing at a CAGR of 15.0% over the analysis period 2023-2030. Medical Technology, one of the segments analyzed in the report, is expected to record a 14.7% CAGR and reach US$19.5 Billion by the end of the analysis period. Growth in the Molecular Technology segment is estimated at 15.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.2% CAGR

The BioImaging Technologies market in the U.S. is estimated at US$3.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.8 Billion by the year 2030 trailing a CAGR of 14.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 13.0% and 12.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Global BioImaging Technologies Market - Key Trends and Drivers Summarized

Bioimaging technologies have revolutionized medical sciences by providing real-time visualization of biological processes. Combining anatomical structure information with functional data such as electrical and magnetic fields, mechanical motion, and metabolic processes, bioimaging offers a comprehensive view of the human body's internal workings. Techniques like X-rays, ultrasound, MRI, and advanced CT scans reveal detailed images of anatomical and cellular structures, crucial for diagnosing and managing diseases. These non-invasive methods allow for detailed examination without physical intrusion, making them invaluable in clinical settings. Bioimaging is an interdisciplinary field integrating electrical, mechanical, and biomedical engineering to address complex biological questions, leading to significant advancements in understanding and treating diseases like cancer.

The advancement of bioimaging is deeply rooted in computational biology and bioinformatics, focusing on high-throughput analysis of cellular and molecular images. Modern automated microscopes and sophisticated computational methods enhance the accuracy and efficiency of data analysis with minimal human intervention. Innovations such as multi-photon imaging, image-guided interventions, and various microscopy techniques have expanded the capabilities of medical diagnostics and therapeutic planning. One critical challenge in bioimaging is the numerical instability associated with image reconstruction, alongside the computational complexity of image processing methods. Recent developments include integrating Artificial Intelligence (AI) and machine learning to enhance image analysis, transforming raw data into actionable medical insights.

Several key factors drive the growth of bioimaging technologies. Advancements in AI and machine learning enable more sophisticated analysis, improving diagnostic accuracy and efficiency. Enhanced computational power and better algorithms allow for faster and more reliable image processing. The increasing demand for personalized medicine necessitates advanced imaging technologies to tailor therapies based on individual physiological and molecular profiles. Expanding biomedical research requires observing and analyzing biological processes at cellular and molecular levels, driving the need for advanced imaging tools. Rising healthcare expenditure, particularly in emerging economies, supports the adoption of bioimaging. Higher patient awareness and expectations for early and accurate diagnoses, along with supportive regulatory policies and cost reductions in imaging technology, further promote the widespread use of bioimaging systems in healthcare. These factors collectively underscore the significant role of bioimaging in modern medical and scientific domains.

Select Competitors (Total 14 Featured) -

  • BioClinica
  • Bracco Imaging SpA
  • Digirad Corporation
  • Esaote SpA
  • Fonar Corporation
  • FUJIFILM SonoSite, Inc.
  • GE Healthcare
  • Hitachi, Ltd.
  • Medtronic, Inc.
  • Philips Healthcare
  • Positron Corporation
  • Siemens Healthineers

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • BioImaging Technologies - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Demand for Advanced Diagnostic Imaging Techniques
    • Growth of Chronic Diseases and Aging Population
    • Advancements in Imaging Modalities and Technologies
    • Rising Adoption of Molecular Imaging and PET Scans
    • Impact of COVID-19 Pandemic on BioImaging Market
    • Government Regulations and Standards for Medical Imaging Devices
    • Expansion of BioImaging Applications in Drug Discovery and Development
    • Development of AI and Machine Learning in BioImaging Analysis
    • Consumer Preferences for Non-Invasive Diagnostic Procedures
    • Role of BioImaging in Personalized Medicine and Targeted Therapies
    • Market Penetration of BioImaging in Oncology and Neurology
    • Influence of Technological Innovations on BioImaging Accuracy and Speed
    • Growth of BioImaging in Academic and Research Institutions
    • Challenges Related to Data Management and Storage in BioImaging
    • Emerging Markets and Growth Opportunities in Developing Regions
    • Future Trends and Innovations in BioImaging Technologies and Applications
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for BioImaging Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Molecular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Molecular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 16: World BioImaging Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: USA 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: USA 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: Canada 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Japan 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: China Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: China 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: China Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: China 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for BioImaging Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Europe 16-Year Perspective for BioImaging Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: France Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: France 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: France Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: France 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Germany 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Italy 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: UK 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: UK 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 74: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Rest of Europe Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Rest of Europe 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Rest of Europe Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Rest of Europe 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • BioImaging Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 80: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Asia-Pacific Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Asia-Pacific 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Asia-Pacific Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Asia-Pacific 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 86: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by Technology - Medical and Molecular - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of World Historic Review for BioImaging Technologies by Technology - Medical and Molecular Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of World 16-Year Perspective for BioImaging Technologies by Technology - Percentage Breakdown of Value Sales for Medical and Molecular for the Years 2014, 2024 & 2030
    • TABLE 89: Rest of World Recent Past, Current & Future Analysis for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of World Historic Review for BioImaging Technologies by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of World 16-Year Perspective for BioImaging Technologies by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION